← Back to Clinical Trials
Recruiting NCT06466876

NCT06466876 Retrieval-Based Word Learning in Autistic Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06466876
Status Recruiting
Phase
Sponsor Louisiana State University and A&M College
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2023-07-28
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 10 Years
Study Type INTERVENTIONAL
Interventions
retrieval-based word learning

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2023-07-28 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Children on the autism spectrum sometimes have difficulty learning new words and using the newly taught information in different situations. In this study, the investigators are testing whether strategies that have been found to improve word learning in non-autistic children will also help autistic children. Specifically, the investigators aim to test whether autistic children learn words more successfully if novel words are taught by repeating the words to the child (re-study) or if the novel words are taught first with labeling each word and then quizzing the child (repeated quizzing). The main questions it aims to answer are: * When teaching nouns (names of exotic animals), is learning stronger if autistic children re-study or engage in repeated quizzing of the newly taught words? * When teaching adjectives (visible features of objects, like a bumpy chair), is learning stronger if autistic children re-study or engage in repeated quizzing of the newly taught adjectives? * Does the word learning condition (re-study vs. repeated quizzing) impact whether autistic children are more successful in demonstrating their knowledge of the newly taught words in different contexts? * Are autistic features related to patterns of word learning? Participants will: * Learn new words with half of the words being taught in one way (re-study) and the other half of the words being taught in the other way (repeated quizzing). * Participate in 5-minute and 1-week tests of the newly taught words to measure child learning. * Complete other language, thinking, and autism clinical assessments.

Eligibility Criteria

Inclusion Criteria: * Children with autism spectrum disorder (ASD) will participate in this study. The study will be 4- to 10-years-old and will already have a community diagnosis of autism spectrum disorder. The diagnosis will be confirmed confirmed using the Autism Diagnostic Observation Schedule - 2nd edition (ADOS-2; Lord et al., 2012). * Because the children will be completing an experimental word learning study that requires the child to verbally produce the newly taught words, children must have verbal communication skills (i.e., be able to speak in at least simple sentences spontaneously), which will be determined in initial correspondence with the child's parent or guardian. * Children's primary language spoken must be English. * All children will pass a hearing screening. * Additionally, all children will score above 75 on the Leiter-3 (Roid, Miller, \& Pomplun, 2013), a nonverbal cognitive assessment. Exclusion Criteria: * Because the word learning study involves the child needing to produce the taught words non-speaking autistic children and minimally speaking autistic children (i.e., is not able to produce at least simple sentences in spontaneous speech) will be excluded from the proposed studies. * If the child has a history of a neurological disorder such as cerebral palsy or a known genetic disorder that causes developmental delays/disorders * If the child has an un-corrected hearing loss.

Contact & Investigator

Central Contact

Eileen K Haebig, PhD

✉ ehaebig1@lsu.edu

📞 225-578-3933

Principal Investigator

Eileen K Haebig, PhD

PRINCIPAL INVESTIGATOR

Louisiana State University Health Sciences Center in New Orleans

Frequently Asked Questions

Who can join the NCT06466876 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 10 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06466876 currently recruiting?

Yes, NCT06466876 is actively recruiting participants. Contact the research team at ehaebig1@lsu.edu for enrollment information.

Where is the NCT06466876 trial being conducted?

This trial is being conducted at Baton Rouge, United States.

Who is sponsoring the NCT06466876 clinical trial?

NCT06466876 is sponsored by Louisiana State University and A&M College. The principal investigator is Eileen K Haebig, PhD at Louisiana State University Health Sciences Center in New Orleans. The trial plans to enroll 64 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology